Abstract:411 Objectives: Acute kidney injury (AKI) often complicates treatment outcomes of hospitalized patients, which manifests as decreased kidney glomerular filtration and results in toxic chemicals accumulating in blood. The pathogenesis of many AKI conditions has implicated reactive oxygen species (ROS) as a major factor. Ongoing research has shown that nanomaterials are superior to their small molecule counterparts due to the ability to control their biodistribution and intrinsic scavenging abilities. We found that selenium-doped carbon quantum dots localize in the kidneys of mice and eliminate ROS to treat and prevent AKI. Methods: Carbon quantum dots with high antioxidant capacity were prepared by doping selenium (SeCQDs) through a hydrothermal treatment. PET imaging of SeCQDs was preformed to evaluate biodistribution using Zr-89 (half life: 78.4 h) after functionalizing with deferoxamine (DFO; 89Zr-DFO-SeCQDs). AKI was induced by intramuscular injection of 50% glycerol into the hindlimbs (8 mL/kg) as well as by intraperitoneal injection of cisplatin (20 mg/kg) in mice. An equivalent dose of amifostine, an FDA approved drug that acts through a similar mechanism for AKI treatment, was used to demonstrate the superiority of SeCQDs for AKI therapy. Results: SeCQDs were found to rapidly and exclusively accumulate in kidneys as the uptake was 25.37±4.51 %ID/g at 4 h post-injection (p.i.) following intravenous administration and up to 72 h p.i. (20.47 %ID/g) using PET imaging (n=3). Blood serum creatinine (CRE) and blood urea nitrogen (BUN) as well as H&E staining of kidney tissue were used to validate therapeutic effects in the AKI models. Therapeutic doses of SeCQDs were found to be 1 µg per mouse for AKI induced using 50% glycerol. Serum CRE and BUN were markedly lower for SeCQDs (0.38±0.08 and 44.2±11.7 mg/dL, respectively) compared to PBS negative controls (1.76±0.42 and 169.2±55.1 mg/dL, respectively) (n=5 for all groups). Moreover, cisplatin-induced AKI was prevented by administering 50 µg of SeCQDs per mouse as determined by serum CRE and BUN for SeCQDs (0.5±0.07 and 93.4±53.3 mg/dL, respectively) compared to PBS negative controls (2.24±0.4 and 199.2±36.4 mg/dL, respectively) (n=5 for all groups). Amifostine at an equivalent dose in each AKI model (based on selenium and sulfur composition) was ineffective to treat either glycerol- (BUN: 129.4±45 mg/dL, CRE: 1.06±0.4 mg/dL) or cisplatin-induced AKI (BUN: 174±24.3 mg/dL, CRE: 2±0.59 mg/dL) (n=5 for all groups). Conclusion: PET imaging elucidated that SeCQDs predominately accumulate in kidneys for as long as 72 h. The high renal accumulation of SeCQDs proved a highly effective therapy for the treatment of AKI induced using 50% glycerol and prevention of AKI from cisplatin due to its antioxidant properties. In the same animal models, amifostine was unsuccessful in AKI treatment and demonstrates the promise of utilizing nanomaterials over small molecule drugs to treat kidney diseases.

SOD Mineralized Zeolitic Imidazole Framework-8 for the treatment of chemotherapy-related acute kidney injury

Pyrocatechol Alleviates Cisplatin-Induced Acute Kidney Injury by Inhibiting ROS Production

Recent Advances in Engineered Nanomaterials for Acute Kidney Injury Theranostics

Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics

Biodegradable Osmium Nanoantidotes for Photothermal‐/Chemo‐ Combined Treatment and Prevent Chemotherapy‐Induced Acute Kidney Injury

Phenylenediamine-Based Carbon Nanodots Alleviate Acute Kidney Injury Via Preferential Renal Accumulation and Antioxidant Capacity.

Treatment of Acute Kidney Injury Using a Dual Enzyme Embedded Zeolitic Imidazolate Frameworks Cascade That Catalyzes In Vivo Reactive Oxygen Species Scavenging

Differentiated management of ROS level in tumor and kidney to alleviate Cis-platinum induced acute kidney injury with improved efficacy

Catalytic Tunable Black Phosphorus/Ceria Nanozyme: A Versatile Oxidation Cycle Accelerator for Alleviating Cisplatin‐Induced Acute Kidney Injury

Reactive Oxygen Species-Scavenging Mesoporous Poly(tannic acid) Nanospheres Alleviate Acute Kidney Injury by Inhibiting Ferroptosis

Natural Metal Polyphenol Nanozyme: Free Radical Scavenging and Antioxidation for the Treatment of Acute Kidney Injury

Multifunctional Nanosystem Based on Ultrasmall Carbon Dots for the Treatment of Acute Kidney Injury

A Novel Bone Marrow Targeted Gadofullerene Agent Protect Against Oxidative Injury in Chemotherapy

Selenium‐Doped Carbon Quantum Dots Act as Broad‐Spectrum Antioxidants for Acute Kidney Injury Management

Recent Advances in Nanomaterials for the Treatment of Acute Kidney Injury

Mackinawite nanozymes as reactive oxygen species scavengers for acute kidney injury alleviation

Enhanced Efficiency of Mitochondria-Targeted Peptide SS-31 for Acute Kidney Injury by Ph-Responsive and AKI-kidney Targeted Nanopolyplexes.

2D-nanomaterials for AKI treatment

Molybdenum-based Nanoclusters Act As Antioxidants and Ameliorate Acute Kidney Injury in Mice

Treating Acute Kidney Injury with Antioxidative Black Phosphorus Nanosheets

Renal-Accumulating Selenium-Doped Carbon Quantum Dots Treat Acute Kidney Injury in Mice